The objective of this study was to investigate whether the menstrual cycle influences multiple sclerosis (MS) symptoms. Seventy-two normally menstruating women (aged 20-50 years) with MS were interviewed. Of the 60 patients with a relapsing-remitting form of MS (RR-MS), 26 (43%) regularly experienced worsening of their MS symptoms in the period just before, or at the beginning of, the menstruation. Significantly more patients of the group reporting no influence of the premenstrual period on MS symptoms were using an oral contraceptive (p = 0.041), suggesting a protective effect. There were 12 patients with the primary chronic progressive form of MS (PCP-MS). None of them experienced an influence of the menstrual cycle on their symptoms. Our...
OBJECTIVE:To evaluate the influence of pregnancy and puerperium on the relapse rate of multiple scle...
Multiple sclerosis (MS) is an autoimmune inflammatory demyelinating central nervous system disorder ...
Multiple sclerosis (MS) is an autoimmune inflammatory demyelinating central nervous system disorder ...
The objective of this study was to investigate whether the menstrual cycle influences multiple scler...
The aim of this study was to assess whether an association exists between the premenstrual period an...
Female gender and hormones have been associated with disease activity in multiple sclerosis (MS). We...
Previous studies showed an increased prevalence of multiple sclerosis (MS) in women, a sex-related d...
OBJECTIVE: To study the effect of natural menopause on multiple sclerosis clinical course. METHODS: ...
A mild prevalence of multiple sclerosis (MS) is present in females (2:1). To elucidate the pathogene...
BackgroundMany women with multiple sclerosis (MS) report fluctuating symptoms across their menstrual...
We investigated MRI activity in MS during the menstrual cycle in relation to physiologic sex hormone...
We investigated MRI activity in MS during the menstrual cycle in relation to physiologic sex hormone...
Given the aging population, with a peak age-specific prevalence that is shifting beyond the age of 5...
BACKGROUND: Increase of MS prevalence in females compared to males, especially in reproductive a...
Multiple sclerosis (MS), a chronic inflammatory demyelinating and degenerative disease of the centra...
OBJECTIVE:To evaluate the influence of pregnancy and puerperium on the relapse rate of multiple scle...
Multiple sclerosis (MS) is an autoimmune inflammatory demyelinating central nervous system disorder ...
Multiple sclerosis (MS) is an autoimmune inflammatory demyelinating central nervous system disorder ...
The objective of this study was to investigate whether the menstrual cycle influences multiple scler...
The aim of this study was to assess whether an association exists between the premenstrual period an...
Female gender and hormones have been associated with disease activity in multiple sclerosis (MS). We...
Previous studies showed an increased prevalence of multiple sclerosis (MS) in women, a sex-related d...
OBJECTIVE: To study the effect of natural menopause on multiple sclerosis clinical course. METHODS: ...
A mild prevalence of multiple sclerosis (MS) is present in females (2:1). To elucidate the pathogene...
BackgroundMany women with multiple sclerosis (MS) report fluctuating symptoms across their menstrual...
We investigated MRI activity in MS during the menstrual cycle in relation to physiologic sex hormone...
We investigated MRI activity in MS during the menstrual cycle in relation to physiologic sex hormone...
Given the aging population, with a peak age-specific prevalence that is shifting beyond the age of 5...
BACKGROUND: Increase of MS prevalence in females compared to males, especially in reproductive a...
Multiple sclerosis (MS), a chronic inflammatory demyelinating and degenerative disease of the centra...
OBJECTIVE:To evaluate the influence of pregnancy and puerperium on the relapse rate of multiple scle...
Multiple sclerosis (MS) is an autoimmune inflammatory demyelinating central nervous system disorder ...
Multiple sclerosis (MS) is an autoimmune inflammatory demyelinating central nervous system disorder ...